This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2010-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- North Brunswick, NJ (US) (2010)
- Ewing, NJ (US) (2012)
Company Filing History:
Years Active: 2010-2025
Title: The Innovative Contributions of Jaquan Kalani Levons
Introduction
Jaquan Kalani Levons, an accomplished inventor based in Ewing, NJ, has made significant strides in the pharmaceutical industry. With a robust portfolio of patents, Levons focuses on innovations that address critical health issues, particularly in the treatment of HIV and AIDS.
Latest Patents
Levons holds two notable patents. The first patent involves bioavailable capsule compositions of an amorphous alpha-(N-sulfonamido)acetamide compound. This innovative formulation includes pharmaceutical capsule compositions that contain the active compound (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide, combined with excipients like polyethylene glycol (PEG), Vitamin E polyethylene glycol succinate, and polyvinylpyrrolidone (PVP). The compositions are designed to enhance the bioavailability of certain pharmaceutical agents.
His second patent outlines crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine, alongside their salts and solvates. This patent emphasizes the pharmaceutical applications of these crystalline forms for treating HIV and AIDS, offering methods to obtain such forms for therapeutic uses.
Career Highlights
Levons is currently employed at Bristol-Myers Squibb Company, a leader in the biopharmaceutical sector, where he contributes to groundbreaking research and development initiatives. His work focuses on advancing drug delivery systems and improving patient outcomes through innovative formulations.
Collaborations
Throughout his career, Levons has collaborated with esteemed professionals in his field, including Chung-Pin H. Chen and Dawn DiGiugno Parker. These partnerships have been instrumental in driving forward research and the development of new therapies.
Conclusion
Jaquan Kalani Levons continues to impact the pharmaceutical landscape with his inventions and patents. His dedication to innovation fosters advancements that could significantly improve treatments for individuals living with HIV and AIDS. As he progresses in his career, Levons exemplifies the spirit of curiosity and ingenuity within the realm of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile